labiotech1d
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
New Scientist on MSN2d
CAR T-cells enable record-breaking 18-year nerve cancer remission
A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...
Healio1d
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
The Scientist2d
Synthetic T Cells Provide Precision Immunosuppression
Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...
Multiple Sclerosis News Today1d
TG Therapeutics advancing CAR T-cell therapy toward Phase 1 trial
TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...
T-Mobile's Starlink beta test will target 'dead zones' — and Verizon and AT&T customers can sign up too
T-Mobile Starlink will offer connectivity in areas not covered by cell towers. Registration for the free beta is open to ...